Patent Term Application for WAINUA® (eplontersen), Patent No. 10,683,499 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-5270

Patent Term Application for WAINUA® (eplontersen), Patent No. 10,683,499

Documents

Comments

Description

OPEN

Comment Period OpensOct 16, 2025

Type	Title	Posted	Comments	Status
Other	Letter to U.S. Patent and Trademark Office	Apr 20, 2026	--

CDER

Patent Term Application

Finnegan, Henderson, Farabow,

Garrett & Dunner, LLP

AstraZeneca AB

WAINUA® (eplontersen)

Patent No. 10,683,499

OPEN